Drawing for ENUMERIX

USPTO serial 98536369

ENUMERIX

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
MAJCHER HARTNETT, MEGAN K
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ENUMERIX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Brian J. Focarino

Brian J. Focarino Cooley LLP1299 Pennsylvania Avenue, NW, Suite 700Washington, DC 20004United States

Goods and services

ClassDescriptionStatusFirst use
001Laboratory reagents for research purposes; enzyme and enzyme preparations for research purposes; polymerase chain reaction (PCR) reagents for research purposes; polymerase chain reaction (PCR) enzymes for research purposes; reverse transcriptions enzymes for research purposes; reagent polymerase chain reaction (PCR) master mixes, namely, pre-mixed reactants and reagents for research purposes; all the following sold individually or together as a kit, for quantitative polymerase chain reaction and quantitative reverse transcription polymerase chain reaction; scientific research kits comprising nucleotides for scientific and research use, diagnostic reagents, enzymes, agents in the nature of biochemical reagents used for non-medical purpose, assays for research purposes, buffer solutions for use in analytical chemistry and molecular biology, chemical preparations for scientific purposes used for nucleic acid sequencing, genotyping, genetics, agriculture, and metagenomics, and biological preparations for use in science used for nucleic acid sequencing, genotyping, genetics, agriculture, and metagenomics, all for use in scientific research other than for medical or veterinary use; chemical, biochemical and biotechnological products for industrial and scientific purposes, namely, diagnostic preparations, except for medical and veterinary medical purposes; reagents and solvents for scientific and research use for the preparation of samples, the modification and manipulation of samples and for performing marking, separation, isolation, purification, reproduction and analysis methods for biopolymers, namely, nucleic acids, proteins, macromolecules and biologically active substances; diagnostic components for molecular biology diagnostic scientific testing, namely, diagnostic reagents for scientific useACTIVE—
005Diagnostic components for molecular biology diagnostic testing, namely, diagnostic reagents for medicinal useACTIVE—
009Imaging apparatus and instruments, namely, non-medical imaging devices for the study of polymerase chain reaction (PCR) testing for scientific research purposes; downloadable software for facilitating and performing polymerase chain reaction (PCR) testing; laboratory equipment, namely, non-medical imaging devices using electronic detection for molecular diagnostics and molecular diagnostics analyzers; laboratory equipment, namely, non-medical imaging devices for use in the quantification of nucleic acids for use in research, translational, and clinical analysis; laboratory equipment, namely, non-medical imaging devices for use in the quality control of gene editing; laboratory equipment, namely, non-medical imaging devices for use in the detection, quantification, and monitoring of nucleic acids and molecular diagnostics.ACTIVE—
042Polymerase chain reaction (PCR) testing for scientific research purposes; scientific consulting and contract research services in the field of polymerase chain reaction (PCR) testingACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Sep 21, 2026MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 21, 2026ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 15, 2026ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Feb 3, 2026EX1GSOU EXTENSION 1 GRANTED—
Feb 3, 2026EXT1SOU EXTENSION 1 FILED—
Feb 3, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 19, 2025NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 24, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 24, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 18, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 23, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 21, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 21, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 21, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 20, 2025XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Feb 20, 2025XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Feb 19, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 19, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 19, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 22, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 22, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 22, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 20, 2024DOCKASSIGNED TO EXAMINER—
Nov 3, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 6, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance